Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database

COVID-19 vaccines and myocarditis

(2021) Mathieu Kerneis et al.   Archives of Cardiovascular Diseases

Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study

(2021) Joe-Elie Salem et al.   EUROPEAN HEART JOURNAL

Recognition and Initial Management of Fulminant Myocarditis

(2020) Robb D. Kociol et al.   CIRCULATION

Cardiovascular Toxicities Associated with Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database

(2020) Lee S. Nguyen et al.   CIRCULATION

Ibrutinib-Mediated Atrial Fibrillation Due to Inhibition of CSK

(2020) Ling Xiao et al.   CIRCULATION

Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

(2020) Carsten Tschöpe et al.   Nature Reviews Cardiology

Cardiovascular toxicities associated with immune checkpoint inhibitors

(2019) Jiun-Ruey Hu et al.   CARDIOVASCULAR RESEARCH

Myocarditis in the Setting of Cancer Therapeutics

(2019) Marc P. Bonaca et al.   CIRCULATION

Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis

(2019) Joe-Elie Salem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Androgenic Effects on Ventricular Repolarization

(2019) Joe-Elie Salem et al.   CIRCULATION

Cardiovascular Toxicities Associated With Ibrutinib

(2019) Joe-Elie Salem et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry

(2018) Enrico Ammirati et al.   CIRCULATION

A systematic review of clozapine-induced myocarditis

(2018) Brandi L. Bellissima et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

An MCEM Framework for Drug Safety Signal Detection and Combination from Heterogeneous Real World Evidence

(2018) Cao Xiao et al.   Scientific Reports

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Spencer L James et al.   LANCET

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

(2018) Joe-Elie Salem et al.   LANCET ONCOLOGY

Eosinophilic Myocarditis

(2017) Michela Brambatti et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Good Signal Detection Practices: Evidence from IMI PROTECT

(2016) Antoni F. Z. Wisniewski et al.   DRUG SAFETY

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

(2016) Douglas B. Johnson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Causality assessment in pharmacovigilance: The French method and its successive updates

(2016) Ghada Miremont-Salamé et al.   THERAPIE

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015) Theo Vos et al.   LANCET

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

(2013) A. L. P. Caforio et al.   EUROPEAN HEART JOURNAL

Recurrence of Myocarditis After Mesalazine Treatment for Ulcerative Colitis

(2012) Tony Sabatini et al.   INFLAMMATORY BOWEL DISEASES

Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery

(2011) G Niklas Norén et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention

(2009) Adriana Albini et al.   JNCI-Journal of the National Cancer Institute

Clozapine-induced myocarditis: Role of catecholamines in a murine model

(2008) Ju-Feng Wang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY